- Patent Title: β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections
-
Application No.: US15645701Application Date: 2017-07-10
-
Publication No.: US10202412B2Publication Date: 2019-02-12
- Inventor: Jean-Pierre Sommadossi , Adel Moussa
- Applicant: Atea Pharmaceuticals, Inc.
- Applicant Address: US MA Boston
- Assignee: Atea Pharmaceuticals, Inc.
- Current Assignee: Atea Pharmaceuticals, Inc.
- Current Assignee Address: US MA Boston
- Agency: Knowles Intellectual Property Strategies, LLC
- Main IPC: C07H19/20
- IPC: C07H19/20 ; C07H19/207 ; C07H19/16 ; A61P31/12
Abstract:
A compound or a pharmaceutically acceptable salt or composition thereof for the treatment of a host infected with or exposed to a virus of the Paramyxoviridae or Orthomyxoviridae family, or other disorders, in particular respiratory syncytial virus, more fully described herein.
Public/Granted literature
Information query
IPC分类:
